Roche’s Virtual Hematology Investor Event
Roche has hosted a virtual event on Monday, 23 June 2025
| Agenda | |
|---|---|
| Introduction | Bruno Eschli, Head of Investor Relations |
| Malignant Hematology Franchise Update | Charles Fuchs, SVP Global Head of Oncology and Hematology, Product Development |
| NHL: FL update; DLBCL: Lunsumio+Polivy - Ph III (SUNMO) Primary Analysis; Columvi - Ph III (STARGLO) 2y data | Charles Fuchs, SVP Global Head of Oncology and Hematology, Product Development |
| Non-Malignant Hematology Franchise Update | Daud Chaudry, Lifecycle Leader Hemophilia Bispecifics, Global Product Strategy |
| Hemophilia: NXT007 - Ph I/II (NXTAGE) Primary Analysis | Daud Chaudry, Lifecycle Leader Hemophilia Bispecifics, Global Product Strategy |
| Q&A |
Webinar Replay
Investors